# Combination Versus Alone Liposomal Bupivacaine Blocks in Minimally Invasive Thoracic Surgery-1

> **NCT07254650** · NA · NOT_YET_RECRUITING · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 300 (estimated)

## Conditions studied

- Lung Cancer (Diagnosis)

## Interventions

- **PROCEDURE:** Arm 1 "LipoB-I": Liposomal Bupivacaine via Multi-Level Intercostal Nerve Block
- **PROCEDURE:** Arm 2 "LipoB-S": Liposomal Bupivacaine via Serratus Anterior Plane Block
- **PROCEDURE:** Arm 3 "LipoB-C": Liposomal Bupivacaine Administered via Combination Block

## Key facts

- **NCT ID:** NCT07254650
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2027-01-01
- **Final completion:** 2028-01-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-11-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07254650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07254650, "Combination Versus Alone Liposomal Bupivacaine Blocks in Minimally Invasive Thoracic Surgery-1". Retrieved via MORVS 2026-10-10 from https://api.morvs.ai/clinical/NCT07254650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*